Previous Close | 4.3000 |
Open | 4.3000 |
Bid | 2.4500 |
Ask | 2.8000 |
Strike | 260.00 |
Expire Date | 2024-12-20 |
Day's Range | 4.3000 - 4.3000 |
Contract Range | N/A |
Volume | |
Open Interest | 6 |
Alcon's (ALC) Q1 results reflect substantial growth in its franchises on the back of healthy markets.
Within Neuromodulation, Boston Scientific's pain business is consistently gaining traction, banking on strength in the spinal cord stimulation (SCS) business.
QIAGEN (QGEN) receives FDA clearance for the QIAstat-Dx respiratory syndromic testing panel for fast and accurate results.